This rare neurological syndrome has previously been reported in association with SARS-CoV-2 infection itself. The patients were treated either with intravenous immunoglobulin, oral steroids, or no treatment. The authors suggest vigilance for cases of bifacial weakness with paraesthesias variant GBS following vaccination for SARS-CoV-2 and that post-vaccination surveillance programs ensure robust data capture of this outcome, to assess for causality.
Allen, C.M., Ramsamy, S., Tarr, A.W., Tighe, P.J., Irving, W.L., Tanasescu, R. and Evans, J.R. (2021), Guillain-Barré syndrome variant occurring after SARS-CoV-2 vaccination. Ann Neurol. Accepted Author Manuscript. https://doi.org/10.1002/ana.26144